A lump or feeling of pressure behind the knee may be a Baker’s cyst, also called a popliteal cyst. Some cysts cause little trouble. Others make bending or straightening the knee uncomfortable, limit walking, or repeatedly fill after drainage.
When I assess this problem, I want to answer two questions: Is the swelling actually a Baker’s cyst, and what is keeping the knee irritated? Treating the fluid collection may relieve pressure, but an ongoing joint problem can allow it to return. At the same time, the cyst itself can contribute to symptoms and should not automatically be dismissed as an incidental finding.
What is a Baker’s cyst?
A Baker’s cyst is a fluid-filled enlargement of a bursa behind the knee, usually between the semimembranosus tendon and the medial head of the gastrocnemius muscle. In adults, it often communicates with the knee joint. Arthritis, a meniscal injury, or an inflammatory joint condition can increase synovial fluid and contribute to that enlargement. The communication may function like a valve, allowing fluid to collect behind the knee. (1)
The name comes from surgeon William Morrant Baker, rather than an occupation. The important issue is the connection between the swelling and the health of the knee. This is not necessarily a problem originating only at the front of the joint, and the cyst does not need to compress the entire knee to cause discomfort.
Meniscal cysts, ganglion cysts, vascular abnormalities, and other masses are different conditions. A new lump should be evaluated rather than identified by location alone.
Can the cyst itself cause pain?
Yes. Tightness, posterior knee pain, fullness, and restricted motion may come from the cyst. Arthritis or another intra-articular condition can cause additional symptoms, including aching, stiffness, or swelling elsewhere around the knee.
A study of 130 people compared knee osteoarthritis alone with osteoarthritis accompanied by a Baker’s cyst. Those with a cyst had a greater symptom burden. Conservative treatment helped both groups initially, but outcomes declined by six months in the cyst group. Because treatments varied with presentation, this was not a randomized comparison proving one treatment was best. (2)
This helps explain why draining the cyst may relieve one component of pain without solving every problem in the knee. Conversely, treating arthritis does not guarantee that a large symptomatic cyst will immediately disappear.
Does a bigger cyst mean worse arthritis?
Some studies associate larger cysts with cartilage damage, joint fluid, or inflammation. That does not make cyst size a reliable grading system for an individual knee.
A 2021 study of 85 surgically treated patients found a moderate association between cartilage-lesion severity and cyst volume. Its selected population and observational design do not establish that every large cyst means advanced arthritis. (3)
A 2024 MRI study included 52 patients: 15 with simple cysts and 37 with complicated cysts. Complicated cysts were associated with several joint findings, but after adjustment for multiple comparisons, synovial proliferation—the thickening or overgrowth of the joint lining—was the finding that remained significant. “Complicated” describes imaging characteristics; it does not automatically mean an emergency or a need for surgery. (4)
A 2025 MRI study found no direct association between the particular medial knee bone measurements it examined and cyst presence. It did find associations involving age and degenerative changes. It was not a test showing that every cyst indicates a bone-on-bone knee. (5)
The practical interpretation is that size and appearance provide clues. They must be considered with the symptoms, examination, and underlying joint findings.
Ultrasound, MRI, and X-rays answer different questions
Ultrasound can show whether a posterior lump contains fluid, characterize the cyst, and assist with a procedure when one is appropriate. A meta-analysis of 13 studies involving 1,011 participants found high accuracy for identifying whether a Baker’s cyst was present. Compared with MRI, pooled sensitivity was approximately 94% and specificity approximately 100%, with uncertainty around those estimates. (6)
That result concerns detection of a cyst. It does not mean ultrasound is equivalent to MRI for assessing every meniscal, cartilage, ligament, or bone abnormality in the knee.
MRI may help when the diagnosis is unclear, an atypical mass needs assessment, or an associated internal knee problem could change management. Weight-bearing X-rays may clarify arthritis and alignment even though they do not directly show the cyst. (1)
If the concern is a blood clot, a venous duplex examination is needed. Identifying a Baker’s cyst on a musculoskeletal scan does not by itself exclude a clot. Interpreting those findings alongside symptoms is particularly important when several abnormalities coexist.
A ruptured cyst can resemble a blood clot
A cyst can leak or rupture, allowing fluid to track into the calf. This can produce sudden pain, swelling, tightness, and sometimes bruising. These symptoms overlap with deep vein thrombosis, so a presumed rupture should not be used to explain away a new swollen calf.
New calf swelling, redness, warmth, or significant pain deserves prompt medical assessment. Chest pain, shortness of breath, or fainting with these symptoms requires emergency care. Severe escalating pain, a tense calf, new weakness or numbness, or a cold foot also needs urgent assessment. (1)
Once a clot and other concerning causes have been assessed, many ruptured cysts can be managed nonsurgically. Treatment must fit the diagnosis rather than be based on an assumption that every calf swelling is joint fluid.
Can a Baker’s cyst cause tingling or nerve symptoms?
Rarely, a large cyst can press on a nearby nerve or blood vessel. A 2023 case report described tibial nerve compression by a Baker’s cyst in a 43-year-old patient. Symptoms improved after surgical decompression when conservative measures had not helped. A single case establishes a possibility, not how often it occurs. (7)
Tibial nerve compression behind the knee is not anatomically the same as tarsal tunnel syndrome, which involves compression near the ankle. Numbness in the foot or radiating leg pain also warrants consideration of other peripheral nerve problems or a lumbar source. A cyst on imaging does not establish that it causes every neurological symptom.
Initial treatment usually addresses symptoms and the underlying knee problem
An asymptomatic cyst may need observation rather than an intervention. For a symptomatic knee, treatment may include modifying aggravating activity, managing swelling, appropriately selected medication, and rehabilitation directed at movement and strength. Osteoarthritis, inflammatory arthritis, and a mechanically significant meniscal tear may require different plans. (1)
The aim is not simply to exercise the lump away. Rehabilitation should account for pain, effusion, limited motion, and the joint’s tolerance of load. Medication decisions need to consider kidney, gastrointestinal, cardiovascular, and other risks.
Persistent locking, significant instability, or a new inability to bear weight changes the assessment. Research supporting conservative care for an ordinary degenerative meniscal tear should not be used to dismiss a physically locked knee or another important structural problem.
Aspiration and corticosteroid injection: what can they accomplish?
Aspiration removes fluid and may reduce pressure. Ultrasound guidance helps visualize the collection and nearby structures, which is particularly important behind the knee where nerves and blood vessels are present. It does not eliminate procedural risks.
A corticosteroid injection may be used to reduce inflammation in a selected joint or cyst-related presentation. An injection into the knee joint and one into the cyst are different targets; the proposed purpose should be clear.
A 2021 publication described successful ultrasound-guided aspiration and corticosteroid injection in one patient with osteoarthritis and a recurrent painful cyst. This was a case report, not a treatment guideline or evidence that the procedure permanently cures most cysts. (8)
Risks include bleeding, infection, a temporary flare, and injury to nearby structures. Steroids also have patient-specific considerations, including effects on blood glucose. Recurrence may occur even after technically successful drainage.
What did the study of ruptured cysts show?
A retrospective study treated 42 patients with ruptured cysts using ultrasound-guided aspiration and corticosteroid injection. Pain and function improved. Calf fluid resolved in 41 patients by 12 weeks, but the cyst itself disappeared in 23. Early recurrence was common, and many patients underwent repeat aspiration. (9)
These are different outcomes: resolution of leaked calf fluid, relief of symptoms, and disappearance of the original cyst. The uncontrolled design and short follow-up limit conclusions about comparative effectiveness. No adverse effects were reported, but a small series cannot establish that a procedure has no risk. (9)
PRP for Baker’s cysts: the new 2026 trial
Platelet-rich plasma, or PRP, is prepared from a patient’s blood and contains concentrated platelets and associated signaling proteins. It is being studied for effects on symptoms and the local tissue environment. It should not be described as established replacement cartilage or a guaranteed way to seal a cyst’s connection to the joint.
A 2026 randomized trial enrolled 36 patients with Baker’s cysts and mild-to-moderate knee osteoarthritis. One group received ultrasound-guided aspiration alone; the other received aspiration followed by PRP injected into the cyst. Outcomes were assessed at six and 12 weeks. (10)
At 12 weeks, the aspiration-plus-PRP group had better pain and WOMAC outcomes than the aspiration-only group. However, the between-group reduction in cyst size was similar. Improvement within the PRP group should not be confused with proof that PRP shrank cysts more than the comparison treatment. (10)
The trial is encouraging direct evidence for short-term symptom improvement in a selected population. It does not establish durable prevention of recurrence, effectiveness in advanced bone-on-bone arthritis, or superiority over aspiration plus corticosteroid. The small sample and 12-week follow-up are important limits.
It also studied injection into the cyst. That cannot automatically be treated as evidence for PRP injected only into the joint, or for every PRP preparation and treatment schedule.
Earlier evidence: a basketball player and an animal study
The earlier article discussed a published case involving a 29-year-old basketball player with post-traumatic osteoarthritis and a popliteal cyst after ACL reconstruction. Aspiration and steroid had provided temporary relief. After two serial leukocyte-rich PRP injections into the knee, the report described resolution of pain and cyst size. (11)
That account remains useful as an individual outcome. It cannot establish the likelihood of success, separate PRP’s effect from other influences, or demonstrate that the meniscus or cartilage regenerated.
The article also cited a rabbit study of PRP for synovitis after surgically induced joint instability. It found changes consistent with reduced inflammation. This is preclinical evidence, not a human Baker’s cyst trial and not proof that PRP repairs the mechanical cause of an unstable knee. (12)
The new randomized trial therefore adds more directly relevant information than the older case report and laboratory rationale, while still leaving important questions unanswered.
What about bone marrow concentrate or other cell-based injections?
Bone marrow concentrate is a different preparation from PRP. It contains mixed cell populations and other components, rather than a purified stem cell population. Research on a treatment for knee arthritis cannot automatically establish that it will eliminate a Baker’s cyst or prevent recurrence.
The 2026 cyst trial used PRP, not marrow concentrate. It therefore cannot support claims that marrow, donor tissue, or an added exosome product would provide the same result or work better. Any proposed treatment needs evidence relevant to the preparation and target.
For a broader explanation, see the site’s comparison of PRP and marrow preparations.
Why does the cyst return, even after treatment?
Persistent joint fluid, synovial inflammation, the cyst’s communication with the joint, and internal complexity can all matter. Reappearance does not automatically mean the knee is rapidly deteriorating or that drainage was performed incorrectly.
Symptoms and imaging can also diverge. A smaller residual cyst may cause little trouble, while a patient whose cyst has disappeared may still have pain from arthritis or another structure. Follow-up should consider function and the cause of symptoms rather than cyst dimensions alone.
When is surgery considered?
Surgery is usually reserved for selected persistent symptomatic cases, recurrent cysts despite appropriate nonsurgical care, a relevant internal joint lesion, or complications such as nerve or vascular compression. The decision should identify what the operation is intended to change. (1)
A 2023 retrospective surgical series of 54 patients found complete cyst disappearance in 20 and reduced size in 34 after arthroscopic decompression and cyst-wall treatment. Degenerative cartilage lesions were associated with a residual cyst. Clinical outcomes improved, illustrating that a residual imaging finding is not identical to persistent clinical failure. (13)
The study cannot establish that everyone with arthritis needs surgery or that removal of a cyst alone resolves the underlying joint condition. Likewise, an incidental meniscal tear on MRI does not by itself establish a need for arthroscopy.
What should a useful treatment plan achieve?
The first priorities are an accurate diagnosis and an explanation of whether the cyst, the joint, or both are generating symptoms. Relevant goals include less posterior pressure, better motion, improved walking, and fewer swelling episodes.
Drainage may help pressure. Treatment of the underlying knee condition may reduce ongoing irritation. PRP now has a small randomized trial suggesting short-term benefit when added to aspiration, but a durable cure cannot be promised.
The cyst should be considered as part of the whole knee, while new calf swelling or neurological symptoms receive their own assessment. That approach is more useful than assuming that every cyst needs removal—or that treating arthritis guarantees it will disappear.
Related JointRehab articles
- Meniscus tears: conservative care, surgery, and injections
- When knee pain is worse after meniscus surgery
- Research comparing different types of knee injections
References
1 American Academy of Orthopaedic Surgeons. Baker’s Cyst (Popliteal Cyst). OrthoInfo. Accessed November 9, 2026.
2 Abate M, Di Carlo L, Di Iorio A, Salini V. Baker’s Cyst with Knee Osteoarthritis: Clinical and Therapeutic Implications. Med Princ Pract. 2021;30(6):585-591. doi:10.1159/000518792.
3 Saylik M, Gokkus K, Sahin MS. Factors affecting Baker cyst volume, with emphasis on cartilage lesion degree and effusion in the young and middle-aged population. BMC Musculoskelet Disord. 2021;22(1):851. doi:10.1186/s12891-021-04721-8.
4 Kim JM, Kang S, Yoon JS. Association of complicated Baker’s cysts with knee pathologies as compared to simple Baker’s cysts. Medicine (Baltimore). 2024;103(23):e38407. doi:10.1097/md.0000000000038407.
5 Imre E, Bozgeyik B. Association between medial knee joint bone morphology and popliteal cyst: a retrospective MRI-based analysis. Skeletal Radiol. 2025;54(9):1863-1871. doi:10.1007/s00256-025-04890-w.
6 Liu K, Li X, Weng Q, Lei G, Jiang T. Diagnostic accuracy of ultrasound for the assessment of Baker’s cysts: a meta-analysis. J Orthop Surg Res. 2022;17(1):535. doi:10.1186/s13018-022-03430-9.
7 Kholinne E, Sumargono E, Harjanti DA, Anestessia IJ. Compression syndromes of the popliteal neurovascular due to Baker cyst: A case report. Int J Surg Case Rep. 2023;105:108013. doi:10.1016/j.ijscr.2023.108013.
8 Fredericksen K, Kiel J. Bedside ultrasound-guided aspiration and corticosteroid injection of a baker’s cyst in a patient with osteoarthritis and recurrent knee pain. J Am Coll Emerg Physicians Open. 2021;2(2):e12424. doi:10.1002/emp2.12424.
9 Mortada M, Amer YA, Zaghlol RS. Efficacy and Safety of Musculoskeletal Ultrasound Guided Aspiration and Intra-Lesional Corticosteroids Injection of Ruptured Baker’s Cyst: A Retrospective Observational Study. Clin Med Insights Arthritis Musculoskelet Disord. 2020;13:1179544120967383. doi:10.1177/1179544120967383.
10 Akarsu O, Aşkin A, Bayram KB, Mert D, Şengül İ. Ultrasound-Guided Aspiration of Baker’s Cyst Combined With Intracystic Platelet-Rich Plasma Injection in Knee Osteoarthritis: A Randomized Controlled Trial. Am J Phys Med Rehabil. 2026; published online June 15, 2026. doi:10.1097/phm.0000000000003065.
11 Song B, Yeh PC, Jayaram P. Leukocyte-rich platelet-rich plasma application in post-traumatic osteoarthritis with popliteal cyst: a case report. Regen Med. 2020;15(6):1695-1702. doi:10.2217/rme-2020-0021.
12 Yin J, Xu Z, Liu J. Alleviation of synovitis caused by joint instability with application of platelet-rich plasma. Thromb Res. 2020;186:20-25. doi:10.1016/j.thromres.2019.11.017.
13 Kim MS, Lee JW, Ahn JH, Min KU, Lee SH. Risk factors for residual popliteal cyst after arthroscopic decompression and cystectomy: Associated with degenerative cartilage lesions. Orthop Traumatol Surg Res. 2023;109(6):103595. doi:10.1016/j.otsr.2023.103595.





